2Zivelin A,Rosenberg N,Faier S,et al.A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene[].Blood.1998
3Poort SR,Michiels JJ,Reitsma PH.Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder[].Thrombosis and Haemostasis.1994
4Rosendaal FR,Siscovicr DS,Schwartx SM,et al.A common prothrombin variant(20210G to A) increase the risk of myocardial infarction in young women[].Blood.1997
5Corral J,Gonzalez CR,Lozano ML,et al.The venous thrombosis risk factor 20210A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease[].British Journal of Haematology.1997
6Longstreth WT,Rosendaal FR,Siscovick DS,et al.Risk of stroke in young women and two prothrombotic mutations: Factor V leiden and prothrombin gene variant (G20210A)[].Stroke.1998
7Arruda VR,Annichino BJM,Goncalves MS,et al.Prevalence of the prothrombin gene variant(nt 20210A) in venous thrombosis and arterial disease[].Thrombosis and Haemostasis.1997
8Rosendaal FR,Doggen CJM,Zivelin A,et al.Geographic distribution of the 20210G to A prothrombin variant[].Thrombosis and Haemostasis.1998
9Franco RF,Elion J,Tavella MH,et al.Heterogeneous distribution of the 20210G→A prothrombin and 677 C→T methylenetetrahydrofolate reductase mutations in different human populations: Relevance for vascular disease risk[].Blood.1997
10Poort SR,Rosendaal FR,Reitsma PH,et al.A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis[].Blood.1996
5ONG A T,HOYE A,AOKI J,et al.Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metel,sirolimus,or paclitaxel stent implantation [ J ].J Am Coll Cardiol,2005,45:947-953.
6GOLDSTEIN J A,BEARDSLEE M A,XU H,et al.Infective endocarditis resulting from CardioSWAL closure of a patent foramen ovale [ J ].Catheter Cardiovasc Interv,2002,55 (2):217-220.
7LINCOFF A M,TOPAZ E J.Intracoronary Stenting compared with conventional therapy for abrup vessel closure complicating coronary angioplasty:a matched case control study[J].J Am Coll Cardid,1992,21:866-869.
8URBAN P,CARLOS M.Randomized evalntion of anticoagnlation versus antiplateldt therapy after coronary stent implantation in high risk patient [ J ].Circulation,1998,98 (20):216-220.
9Naresh R,Rosemary JP,Amelia SK,et al.The role ofechocardiography and its com parison with NT-pro-BNP measurem ents in patients with acute myocardial in farction[J].Med Sci Monit,2007,3(12):547-578.
10Krishnaswamy P,Lubien E,Clopton P,et al.Utility of B-natriuretic peptide levels in identifying patients with leftventricular systolic or diastolic dysfunction[J].Am J Med,2001,111(4):274-279.
